Mapping complex disease loci in whole-genome association studies

Nature

Volumn 429, Issue 6990, 2004, Pages 446-452

  Carlson, Christopher S ^a   Eberle, Michael A ^c   Kruglyak, Leonid ^b,c   Nickerson, Deborah A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; DRUG THERAPY; GENES; GENETIC ENGINEERING;

GENETIC LINKAGE; WHOLE-GENOME ASSOCIATION;

BIOMEDICAL ENGINEERING;

BIOLOGY; GENOME;

DISEASE PREDISPOSITION; FEASIBILITY STUDY; GENE INTERACTION; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOME; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW;

DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, MEDICAL; GENOME, HUMAN; HUMANS; LINKAGE (GENETICS); PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 2642583283     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature02623     Document Type: Review

References (66)

1. Botstein, D. & Risch, N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nature Genet. 33 (suppl.), 228-237 (2003).
2. Grody, W. W. et al. PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population. Am. J. Hum. Genet. 60, 935-947 (1997).
3. Kosorok, M. R., Wei, W. H. & Farrell, P. M. The incidence of cystic fibrosis. Stat. Med. 15, 449-462 (1996).
4. Rocchi, A., Pellegrini, S., Siciliano, G. & Murri, L. Causative and susceptibility genes for Alzheimer's disease: a review. Brain Res. Bull. 61, 1-24 (2003).
5. Collins, F. S., Guyer, M. S. & Chakravarti, A. Variations on a theme: cataloging human DNA sequence variation. Science 278, 1580-1581 (1997).
6. Slooter, A. J. et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch. Neurol. 55, 964-968 (1998).
7. Risch, N. & Merikangas, K. The future of genetic studies of complex human diseases. Science 273, 1516-1517(1996).
8. Lohmueller K. E., Pearce, C. L., Pike, M., Lander, E. S. & Hirschhorn, J. N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nature Genet. 33,177-182 (2003).
9. Reich, D. E. & Lander, E. S. On the alletic spectrum of human disease. Trends Genet. 17, 502-510 (2001).
10. Patil, N. et al. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 294, 1719-1723 (2001).
11. Sachidanandam, R. et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409, 928-933 (2001).
12. Zondervan, K. T. & Cordon, L. R. The complex interplay among factors that influence allelic association. Nature Rev. Genet. 5, 89-100 (2004).
13. Kruglyak, L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nature Genet. 22, 139-144 (1999).
14. Zhang, K., Calabrese, P., Nordborg, M. & Sun, F. Haplotype block structure and its applications to association studies: power and study designs. Am. J. Hum. Genet. 71, 1386-1394 (2002).
15. Risch, N. & Teng, J. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling. Genome Res. 8, 1273-1288 (1998).
16. Risch, N. Evolving methods in genetic epidemiology. II. Genetic linkage from an epidemiologic perspective. Epidemiol. Rev. 19, 24-32 (1997).
17. The International HapMap Consortium. The International HapMap Project. Nature 426, 789-796 (2003).
18. Carlson, C. S. et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 74, 106-120 (2004).
19. Ke, X. & Cardon, L. R. Efficient selective screening of haplotype tag SNPs. Bioinformatics 19, 287-288 (2003).
20. Stram, D. O. et al. Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum. Hered. 55, 27-36 (2003).
21. Weale, M. E. et al. Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: Implications for linkage-disequilibrium gene mapping. Am. J. Hum. Genet. 73, 551-565 (2003).
22. Johnson, G. C. et al. Haplotype tagging for the identification of common disease genes. Nature Genet. 29, 233-237 (2001).
23. Gabriel, S. B. et al. The structure of haplotype blocks in the human genome. Science 296, 2225-2229 (2002).
24. Collins, F. S., Green, E. D., Guttmacher, A. E. & Guyer, M. S. A vision for the future of genomics research. Nature 422, 835-847 (2003).
25. Devlin, B. & Risch, N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29, 311-322 (1995).
26. Lander, E. & Kruglyak, L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nature Genet. 11, 241-247 (1995).
27. Sawcer, S. et al. Empirical genomewide significance levels established by whole genome simulations. Genet. Epidemiol. 14, 223-229 (1997).
28. A meta-analysis of whole genome linkage screens in multiple sclerosis. J. Neuroimmunol. 143, 39-46 (2003).
29. Collins, F. S., Brooks, L. D. & Chakravarti, A. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res. 8, 1229-1231 (1998).
30. Halushka, M. K. et al. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nature Genet. 22, 239-247 (1999).
31. Cargill, M. et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature Genet. 22, 231-238 (1999).
32. Stephens, J. C. et al. Haplotype variation and linkage disequilibrium in 313 human genes. Science 293, 489-493 (2001).
33. Schwartz, S. et al. MultiPipMaker and supporting tools: Alignments and analysis of multiple genomic DNA sequences. Nucleic Acids Res. 31, 3518-3524 (2003).
34. Mayor, C. et al. VISTA: visualizing global DNA sequence alignments of arbitrary length. Bioinformatics 16, 1046-1047 (2000).
35. Boffelli, D. et al. Phylogenetic shadowing of primate sequences to find functional regions of the human genome. Science 299, 1391-1394 (2003).
36. Thomas, J. W. et al. Comparative analyses of multi-species sequences from targeted genomic regions. Nature 424, 788-793 (2003).
37. Bansal, A. et al. Association testing by DNA pooling: an effective initial screen. Proc. Natl. Acad. Sci. USA 99, 16871-16874 (2002).
38. Mohlke, K. L. et al. High-throughput screening for evidence of association by using mass spectrometry genotyping on DNA pools. Proc. Natl. Acad. Sci. USA 99, 16928-16933 (2002).
39. Howell, W. M., Evans, P. R., Wilson, P. J., Cawley, M. I. & Smith, J. L. HLA class II DR, DQ, and DP restriction fragment length polymorphisms in rheumatoid arthritis. Ann. Rheum. Dis. 48, 295-301 (1989).
40. Yang, Y. et al. Efficiency of single-nucleotide polymorphism haplotype estimation from pooled DNA. Proc. Natl. Acad. Sci. USA 100, 7225-7230 (2003).
41. Permutt, M. A. et al. Searching for type 2 diabetes genes on chromosome 20. Diabetes 51 (suppl. 3), S308-S315 (2002).
42. Barcellos, L. F. & Thomson, G. Genetic analysis of multiple sclerosis in Europeans. J. Neuroimmunol. 143, 1-6 (2003).
43. Kammerer, S. et al. Amino acid variant in the kinase binding domain of dual-specific A kinase-anchoring protein 2: a disease susceptibility polymorphism. Proc. Natl. Acad. Sci. USA 100, 4066-4071 (2003).
44. Sham, P., Bader, J. S., Craig, I., O'Donovan, M. & Owen, M. DNA pooling: A tool for large-scale association studies. Nature Rev. Genet. 3, 862-871 (2002).
45. Cristea, I. M., Gaskell, S. J. & Whetton, A. D. Proteomics techniques and their application to hematology. Blood 103, 3624-3634 (2004).
46. Haufroid, V. & Lison, D. Urinary cotinine as a tobacco-smoke exposure index: a minireview. Int. Arch. Occup. Environ. Health 71, 162-168 (1998).
47. Schork, N. J. Power calculations for genetic association studies using estimated probability distributions. Am. J. Hum. Genet. 70,1480-1489 (2002).
48. Storey, J. D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100, 9440-9445 (2003).
49. Bolk, S. et al. A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. Proc Natl. Acad. Sci. USA 97,268-273 (2000).
50. Zetterberg, H., Zafiropoulos, A., Spandidos, D. A., Rymo, L. & Blennow, K. Gene-gene interaction between fetal MTHFR 677C>T and transcobalamin 776C>G polymorphisms in human spontaneous abortion. Hum. Reprod. 18,1948-1950 (2003).
51. Butt, C. et al. Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction. Blood 101, 3037-3041 (2003).
52. Tiret, L. et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 344, 910-913 (1994).
53. Dahlquist, K. D., Salomonis, N., Vranizan, K., Lawlor, S. C. & Conklin, B. R. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nature Genet. 31, 19-20 (2002).
54. Bonner, A. E., Lemon, W. J. & You, M. Gene expression signatures identify novel regulatory pathways during murine lung development: implications for lung tumorigenesis. J. Med. Genet. 40, 408-417 (2003).
55. Harris, M. A. et al. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 32, D258-D261 (2004).
56. Zeeberg, B. R. et al. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol. 4, R28 (2003).
57. Edgar, R., Domrachev, M. & Lash, A. E. Gene Expression Omnibus: NCB1 gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207-210 (2002).
58. Khoury, M. J. & Flanders, W. D. Nontraditional epidemiologic approaches in the analysis of gene environment interact ion: case-control studies with no controls! Am. J. Epidemiol. 144, 207-213 (1996).
59. Begg, C. B. & Zhang, Z. F. Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol. Biomarkers Prev. 3, 173-175 (1994).
60. Piegorsch, W. W., Weinberg, C. R. & Taylor, J. A. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat. Med. 13, 153-162 (1994).
61. Pritchard, J. K. & Przeworski, M. Linkage disequilibrium in humans: models and data. Am. J. Hum. Genet. 69, 1-14 (2001).
62. Jarvik, G. P. et al. Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype. Arterioscler. Thromb. Vasc. Biol. 20, 2441-2447 (2000).
63. Adkins, S., Gan, K. N., Mody, M. & La Du, B. N. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am. J. Hum. Genet. 52, 598-608 (1993).
64. Humbert, R. et al. The molecular basis of the human serum paraoxonase activity polymorphism. Nature Genet. 3, 73-76 (1993).
65. Brophy, V. H. et al. Effects of 5′ regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am. J. Hum. Genet. 68, 1428-1436 (2001).
66. Jarvik, G. P. et al. Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease. Arterioscler. Thromb. Vasc. Biol. 23, 1465-1471 (2003).